140 related articles for article (PubMed ID: 31019982)
1. Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope.
Dorgham K; Pietrancosta N; Affoune A; Lucar O; Bouceba T; Chardonnet S; Pionneau C; Piesse C; Sterlin D; Guardado-Calvo P; Karoyan P; Debré P; Gorochov G; Vieillard V
J Immunol Res; 2019; 2019():9804584. PubMed ID: 31019982
[TBL] [Abstract][Full Text] [Related]
2. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
Wu C; Raheem IT; Nahas DD; Citron M; Kim PS; Montefiori DC; Ottinger EA; Hepler RW; Hrin R; Patel SB; Soisson SM; Joyce JG
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2317230121. PubMed ID: 38768344
[TBL] [Abstract][Full Text] [Related]
3. Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.
Zhou M; Meyer T; Koch S; Koch J; von Briesen H; Benito JM; Soriano V; Haberl A; Bickel M; Dübel S; Hust M; Dietrich U
Eur J Immunol; 2013 Feb; 43(2):499-509. PubMed ID: 23180650
[TBL] [Abstract][Full Text] [Related]
4. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
5. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
[TBL] [Abstract][Full Text] [Related]
7. Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition.
Bhowmick A; Salunke DM
Int Immunol; 2013 Feb; 25(2):77-90. PubMed ID: 22968994
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
Virology; 2017 May; 505():113-126. PubMed ID: 28237764
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.
Lucar O; Su B; Potard V; Samri A; Autran B; Moog C; Debré P; Vieillard V
EBioMedicine; 2017 Aug; 22():122-132. PubMed ID: 28712768
[TBL] [Abstract][Full Text] [Related]
11. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
Zhou M; Kostoula I; Brill B; Panou E; Sakarellos-Daitsiotis M; Dietrich U
Vaccine; 2012 Mar; 30(11):1911-6. PubMed ID: 22269872
[TBL] [Abstract][Full Text] [Related]
12. Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.
Bird GH; Irimia A; Ofek G; Kwong PD; Wilson IA; Walensky LD
Nat Struct Mol Biol; 2014 Dec; 21(12):1058-67. PubMed ID: 25420104
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.
Falkowska E; Le KM; Ramos A; Doores KJ; Lee JH; Blattner C; Ramirez A; Derking R; van Gils MJ; Liang CH; Mcbride R; von Bredow B; Shivatare SS; Wu CY; Chan-Hui PY; Liu Y; Feizi T; Zwick MB; Koff WC; Seaman MS; Swiderek K; Moore JP; Evans D; Paulson JC; Wong CH; Ward AB; Wilson IA; Sanders RW; Poignard P; Burton DR
Immunity; 2014 May; 40(5):657-68. PubMed ID: 24768347
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.
Bianchi E; Joyce JG; Miller MD; Finnefrock AC; Liang X; Finotto M; Ingallinella P; McKenna P; Citron M; Ottinger E; Hepler RW; Hrin R; Nahas D; Wu C; Montefiori D; Shiver JW; Pessi A; Kim PS
Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10655-60. PubMed ID: 20483992
[TBL] [Abstract][Full Text] [Related]
15. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S
Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514
[TBL] [Abstract][Full Text] [Related]
16. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
17. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
[TBL] [Abstract][Full Text] [Related]
18. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
[TBL] [Abstract][Full Text] [Related]
19. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
[TBL] [Abstract][Full Text] [Related]
20. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
Cleveland SM; Jones TD; Dimmock NJ
J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
